Literature DB >> 1730390

Identification and characterization of alternatively spliced fibronectin mRNAs expressed in early Xenopus embryos.

D W DeSimone1, P A Norton, R O Hynes.   

Abstract

Sequence analysis of cDNA clones encoding fibronectin (FN) from Xenopus laevis reveals extensive amino acid identities with other vertebrate FNs, including the presence of the Arg-Gly-Asp (RGD) cell attachment site in type III-10 and of a second, cell-binding site (EILDV) in the alternative spliced V region of the protein. These cDNAs have been used to study the expression of FN mRNAs during early development. Overall, levels of maternal FN mRNA remain constant until the mid- to late-gastrula stage when the accumulation of new FN transcripts is first apparent. RNase protection analyses reveal that the pattern of FN alternative splicing is similar to that reported for other species and does not change with the shift from maternal to zygotic mRNA expression. The cellular forms of the FN protein predominate in the early embryo with the EIIIA and EIIIB exons included in most mRNAs at this time. A comparison of V-region alternative splicing between embryonic and adult liver RNAs indicates a segment of 345 nucleotides that can be either completely excluded or included in mature FN transcripts but there is no evidence for additional V-region variants. Maternal mRNAs encoding alternatively spliced forms of FN can be specifically eliminated from Xenopus oocytes following the injection of antisense oligodeoxynucleotides into the cytoplasm, thereby making it possible to analyze the structure, composition, and function of FN mRNAs in early embryos.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730390     DOI: 10.1016/0012-1606(92)90291-n

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  22 in total

1.  Specificity of antisense oligonucleotides in vivo.

Authors:  T M Woolf; D A Melton; C G Jennings
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

2.  Characterization of mouse fibronectin alternative mRNAs reveals an unusual isoform present transiently during liver development.

Authors:  G K Górski; M C Aros; P A Norton
Journal:  Gene Expr       Date:  1996

3.  Novel form of fibronectin from zebrafish mediates infectious hematopoietic necrosis virus infection.

Authors:  Xiangyu Liu; Paul Collodi
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

Review 4.  The extracellular matrix in development and morphogenesis: a dynamic view.

Authors:  Tania Rozario; Douglas W DeSimone
Journal:  Dev Biol       Date:  2009-10-23       Impact factor: 3.582

5.  Alternative splicing of the fibronectin EIIIB exon depends on specific TGCATG repeats.

Authors:  L P Lim; P A Sharp
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

Review 6.  Fibronectins, their fibrillogenesis, and in vivo functions.

Authors:  Jean E Schwarzbauer; Douglas W DeSimone
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

7.  Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing.

Authors:  L F Brown; D Dubin; L Lavigne; B Logan; H F Dvorak; L Van de Water
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

8.  Further analysis of cytoplasmic polyadenylation in Xenopus embryos and identification of embryonic cytoplasmic polyadenylation element-binding proteins.

Authors:  R Simon; J D Richter
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

Review 9.  New insights into form and function of fibronectin splice variants.

Authors:  E S White; F E Baralle; A F Muro
Journal:  J Pathol       Date:  2008-09       Impact factor: 7.996

10.  The physical state of fibronectin matrix differentially regulates morphogenetic movements in vivo.

Authors:  Tania Rozario; Bette Dzamba; Gregory F Weber; Lance A Davidson; Douglas W DeSimone
Journal:  Dev Biol       Date:  2008-12-30       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.